EMRO is continuously striving to improve on the methods patients are treated. There are a number of areas in which we research and recruit, including:
- Traumatic Brain Injury: New Test for Brain Injury on Horizon
- Acute Heart Failure
- Crash Injuries
- Black Widow Spider Bite: An article about a patient’s experiences with UVA research and Dr. Holstege
- Ischemic Strokes
- Thrombosis
- Acute Transient Ischemic Attack
- Biomarkers
Actively Enrolling Clinical Studies
Study |
Enrollment Criteria |
Hours/Contact |
|---|---|---|
| ESETT #18470 The Established Status Epilepticus Treatment Trial |
· Age: ≥ 18 · Witnessed to seize for >5 minute duration prior to treatment with study drug · Continued or recurring seizure in the Emergency Department |
Enrollment 24/7 PI: J. Stephen Huff, MD |
| LEAP!2 #19126 Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults with Pneumonia |
· Age: ≥18 · Symptomatic CABP · PORT Score 50-130 · No hospitalization within 90 days · Single dose of short-acting antibiotics allowed |
Enrollment: M-F 7-7 CRC PIC 1044 PI: Sara Sutherland, MD |
| ETTAU-03 #19522 Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria |
· Age: ≥18 · Injectable treatment · Symptoms of urticaria |
Enrollment: M-F 7-7 CRC PIC 1044 PI: Thomas Hartka, MD |
| VIOLET #19850 Vitamin D to Improve Outcomes by Leveraging Early Treatment (VIOLET) |
· Age: ≥18 · Enteric Vitamin D vs Placebo · Intent to admit to ICU · ARDS risk: PNA, aspiration, smoke inhalation, lung contusion, sepsis, pancreatitis, acute resp failure |
Enrollment: M-F 7-7 CRC PIC 1044 PI: Enfield/Sochor |
| StandUP #19674 Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure (STANDUP AHF) |
· Age: ≥18 · History of HF + LVEF ≤40% · BNP≥400 · SBP 105-160 · No ACS hosp w/i 90 days |
Enrollment: M-F 7-7 CRC PIC 1044 PI: Chris Ghaemmaghami, MD |
Upcoming Clinical Studies
Winter 2017-2018
Cempra Pediatric Pneumonia – Dr. Easter PI
Crash Injury Research and Engineering Network (CIREN) – Dr. Hartka PI